Compare BGDE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGDE | NTRB |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 36.0M |
| IPO Year | 2013 | 2019 |
| Metric | BGDE | NTRB |
|---|---|---|
| Price | $6.86 | $3.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 67.3K | 6.9K |
| Earning Date | N/A | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $39,754,085.00 | $2,036,651.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $50.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.58 | $2.80 |
| 52 Week High | $11.69 | $8.63 |
| Indicator | BGDE | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 55.79 |
| Support Level | $4.79 | $2.91 |
| Resistance Level | $9.34 | $3.16 |
| Average True Range (ATR) | 0.73 | 0.11 |
| MACD | 0.26 | 0.04 |
| Stochastic Oscillator | 85.50 | 73.29 |
Big Digital Energy Inc, formerly Mawson Infrastructure Group Inc is focused on digital infrastructure platforms. It designs, builds and operates next-generation digital infrastructure platforms for enterprise customers and for its own purposes. The company provides services spanning AI, HPC, digital assets including Bitcoin mining, and other intensive compute applications. The company delivers both self-mining operations and colocation services to enterprise customers with a vertically integrated infrastructure model built for scalability and efficiency. The company also has an energy management business, which utilizes software and analysis, to generate revenue by participating in energy management programs. It operates as one energy management and digital asset mining segment.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.